ZH
RU
ES
Phase IV Clinical Trial Evaluation
Phase IV Clinical Trial Evaluation, Total:25 items.
In the international standard classification, Phase IV Clinical Trial Evaluation involves: Medical sciences and health care facilities in general, Dentistry, Laboratory medicine.
Professional Standard - Agriculture, Phase IV Clinical Trial Evaluation
- 农业部1247号公告-4-2009 Guiding Principles for Phase II and Phase III Clinical Drug Efficacy Evaluation Trials of Antibacterial Drugs
- 农业部1247号公告-6-2009 Guiding principles for preclinical toxicology evaluation tests of veterinary drugs
Group Standards of the People's Republic of China, Phase IV Clinical Trial Evaluation
- T/CGCPU 006-2023 Specification for competency assessment of phase I clinical trials
- T/CGCPU 006-2019 Phase I Clinical Trial Capacity Evaluation Criteria
- T/CACM 1353-2021 Technical guidelines for clinical trial design and evaluation of traditional Chinese medicine in the treatment of carotid atherosclerosis
- T/CACM 1333.1-2019 Technical guidelines for the design and evaluation of traditional Chinese medicine clinical trials for common diseases in the pediatric system Part 1: Anorexia
- T/CACM 1333.4-2019 Technical guidelines for the design and evaluation of traditional Chinese medicine clinical trials for pediatric series of common diseases Part 4: Diarrhea in children
- T/CACM 1333.3-2019 Technical guidelines for the design and evaluation of traditional Chinese medicine clinical trials for pediatric common diseases Part 3: Functional abdominal pain
- T/CACM 1333.2-2019 Technical guidelines for the design and evaluation of traditional Chinese medicine clinical trials for common diseases in the pediatric system Part 2: functional constipation
RU-GOST R, Phase IV Clinical Trial Evaluation
- GOST R 54328-2011 Dentistry. Preclinical evaluation of dental implant systems. Animal test methods
- GOST R 53022.2-2008 Clinical laboratory technologies. Requirements for quility of clinical laboratory tests. Part 2. Assessment of methods analytical reliability (accuracy, censitivity, specificity)
Professional Standard - Medicine, Phase IV Clinical Trial Evaluation
- YY/T 0522-2009 Dentistry Preclinical evaluation of dental implant systems Animal test methods
- YY/T 0268-2001 Dentistry----Preclinical evaluation of biocompatibility of medical devices used in dentistry----Part 1:Evaluation and test methods selection
- YY/T 0688.2-2010 Clinical laboratory testing and in vitro diagnostic test systems.Susceptibility testing of infectious agents and evaluation of performance of antimicrobial susceptibility devices.Part 2 : Evaluation of performance of antimicrobial susceptibility test devi
- YY/T 0127.11-2001 Dentistry----Preclinical evaluation of biocompatibility of medical devices used in dentistry----Part 2:Biological evaluation test method of dental materials----Pulp capping test
KR-KS, Phase IV Clinical Trial Evaluation
AENOR, Phase IV Clinical Trial Evaluation
- UNE-EN ISO 20776-2:2008 Clinical laboratory testing and in vitro diagnostic test systems - Susceptibility testing of infectious agents and evaluation of performance of antimicrobial susceptibility test devices - Part 2: Evaluation of performance of antimicrobial susceptibility t
- UNE-EN ISO 20776-1:2007 Clinical laboratory testing and in vitro diagnostic test systems - Susceptibility testing of infectious agents and evaluation of performance of antimicrobial susceptibility test devices - Part 1: Reference method for testing the in vitro activity of antim
GOSTR, Phase IV Clinical Trial Evaluation
- GOST R ISO 20776-2-2010 Clinical laboratory testing and in vitro diagnostic test systems. Susceptibility testing of infectious agents and evaluation of performance of antimicrobial susceptibility test devices. Part 2. Evaluation of performance of antimicrobial susceptibility tes
- GOST R ISO 20776-1-2010 Clinical laboratory testing and in vitro diagnostic test systems. Susceptibility testing of infectious agents and evaluation of performance of antimicrobial susceptibility test devices. Part 1. Reference method for testing the in vitro activity of antimic
Association Francaise de Normalisation, Phase IV Clinical Trial Evaluation
- NF S92-053-2*NF EN ISO 20776-2:2022 Clinical laboratory testing and in vitro diagnostic test systems - Susceptibility testing of infectious agents and evaluation of performance of antimicrobial susceptibility test devices - Part 2 : evaluation of performance of antimicrobial susceptibility
European Committee for Standardization (CEN), Phase IV Clinical Trial Evaluation
- prEN ISO 20776-2:2021 Clinical laboratory testing and in vitro diagnostic test systems - Susceptibility testing of infectious agents and evaluation of performance of antimicrobial susceptibility test - Part 2: Evaluation of performance of antimicrobial susceptibility test devi
- EN ISO 7405:1997 Dentistry - Preclinical Evaluation of Biocompatibility of Medical Devices Used in Dentistry - Test Methods for Dental Materials ISO 7405: 1997
British Standards Institution (BSI), Phase IV Clinical Trial Evaluation
- 21/30425530 DC BS EN ISO 20776-2. Clinical laboratory testing and in vitro diagnostic test systems. Susceptibility testing of infectious agents and evaluation of performance of antimicrobial susceptibility test. Part 2. Evaluation of performance of antimicrobial susc...
- BS EN ISO 20776-2:2021 Tracked Changes. Clinical laboratory testing and in vitro diagnostic test systems. Susceptibility testing of infectious agents and evaluation of performance of antimicrobial susceptibility test devices. Evaluation of performance of antimicrobial suscep...